Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Cytokinetics (NQ: CYTK ) 53.81 -1.16 (-2.11%) Streaming Delayed Price Updated: 4:00 PM EDT, Oct 21, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Cytokinetics < Previous 1 2 3 4 5 6 7 Next > 2 Biotechs That Could Get Bought Out in 2024 January 03, 2024 These two biotechs have been frequent visitors to the buyout-rumor mill and for good reason. Via The Motley Fool Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet December 29, 2023 Each week, Benzinga's Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the surface and warrant attention. Via Benzinga Cytokinetics Stock Jumps To Higher RS Level; Shoots Up On Heart Drug Study December 28, 2023 On Thursday, Cytokinetics stock cleared a key performance benchmark, with its Relative Strength Rating jumping to 99 from 89 the day before. Via Investor's Business Daily Cytokinetics' Drug Potential: Analyst Suggests Key Role Of Established Pharma For Potential Launch December 28, 2023 On Wednesday, Cytokinetics Incorporated (NASDAQ: CYTK) released topline results from the SEQUOIA-HCM Phase 3 trial of aficamten in patients with symptomatic obstructive hypertrophic cardiomyopathy... Via Benzinga Microsoft To Rally Over 20%? Here Are 10 Top Analyst Forecasts For Thursday December 28, 2023 Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Via Benzinga Cytokinetics Inc. (NASDAQ: CYTK) Leading the Way in Thursday Trading Based on Percentage Gain December 21, 2023 Via Investor Brand Network Expert Ratings for Cytokinetics November 09, 2023 Via Benzinga Expert Ratings for Cytokinetics October 09, 2023 Via Benzinga Crude Oil Falls Over 1%; First Wave BioPharma Shares Spike Higher December 27, 2023 U.S. stocks traded mixed toward the end of trading, with the S&P 500 and Nasdaq Composite moving lower on Wednesday. The Dow traded up 0.05% to 37,564.54 while the NASDAQ fell 0.04% to 15,069.30. The... Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities Why Reneo Pharmaceuticals Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session December 27, 2023 Shares of Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM) shares rose sharply during Wednesday’s session after Concentra sent an acquisition proposal to acquire 100% of equity of the company for $1.80 per... Via Benzinga Why Is Cytokinetics (CYTK) Stock Up 70% Today? December 27, 2023 With Cytokinetics hitting a homerun with its heart failure drug, CYTK stock skyrocketed in part due to takeover interest. Via InvestorPlace Where Cytokinetics Stands With Analysts August 22, 2023 Via Benzinga 10 Health Care Stocks Whale Activity In Today's Session December 27, 2023 Via Benzinga Stocks Static As Post-Holiday Doldrums Hit December 27, 2023 Stocks are struggling for direction today, as the post-holiday doldrums take full effect. Via Talk Markets 12 Health Care Stocks Moving In Wednesday's Intraday Session December 27, 2023 Via Benzinga Gold Gains 1%; Richmond Fed Manufacturing Index Falls In December December 27, 2023 U.S. stocks traded higher midway through trading, with the Dow Jones index gaining around 80 points on Wednesday. The Dow traded up 0.22% to 37,626.76 while the NASDAQ rose 0.06% to 15,084.02. The S&P... Via Benzinga Topics Economy Stocks Exposures Interest Rates US Equities Why Is Heart Disease Focused Cytokinetics Stock Trading Higher Today? December 27, 2023 Cytokinetics Incorporated (NASDAQ: CYTK) released topline results from the SEQUOIA-HCM Phase 3 trial of aficamten in patients with symptomatic obstructive Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session December 27, 2023 Via Benzinga Why CarMax Shares Are Trading Higher By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session December 21, 2023 Shares of CarMax, Inc. (NYSE: KMX) moved higher during Thursday’s session following better-than-expected quarterly earnings. Via Benzinga 10 Health Care Stocks Whale Activity In Today's Session December 14, 2023 Via Benzinga Potential Takeover In Works for Cardiovascular Treatment Focused Cytokinetics November 01, 2023 Cytokinetics Inc (NASDAQ: CYTK), a late-stage biotech company focused on cardiovascular treatments, is reportedly exploring potential takeover options as it has garnered interest from at least one... Via Benzinga HC Wainwright & Co. Maintains Buy Rating for Cytokinetics: Here's What You Need To Know October 20, 2023 Via Benzinga Union Pacific To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Friday October 20, 2023 Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page Via Benzinga 10 Health Care Stocks Whale Activity In Today's Session October 10, 2023 Via Benzinga Why CalAmp Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Friday's Mid-Day Session October 06, 2023 Gainers Via Benzinga NuScale Power, Stagwell And Other Big Stocks Moving Higher On Friday October 06, 2023 U.S. stocks traded higher, with the Nasdaq Composite gaining around 50 points on Friday. Here are some big stocks recording gains in Friday's session. Via Benzinga Topics Stocks Exposures US Equities 10 Health Care Stocks Whale Activity In Today's Session October 05, 2023 Via Benzinga The 3 Best Mid-Cap Stocks to Buy Now: September 2023 September 07, 2023 With the best mid-cap stocks to buy, investors get the best of both worlds: an established business but with ample room to grow. Via InvestorPlace 10 Health Care Stocks With Whale Alerts In Today's Session September 05, 2023 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For August 15, 2023 August 15, 2023 Via Benzinga < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.